Vistide

Vistide is a brand name of cidofovir, approved by the FDA in the following formulation(s):

VISTIDE (cidofovir - injectable; injection)

• 
  Manufacturer: GILEAD
  
  Approval date: June 26, 1996
  
  Strength(s): EQ 75MG BASE/ML ^[RLD]

Has a generic version of Vistide been approved?

No. There is currently no therapeutically equivalent version of Vistide available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Vistide. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Vistide.

See also...

• Vistide Consumer Information (Wolters Kluwer)
• Vistide Consumer Information (Cerner Multum)
• Vistide Advanced Consumer Information (Micromedex)
• Vistide AHFS DI Monographs (ASHP)
• Cidofovir Consumer Information (Wolters Kluwer)
• Cidofovir Consumer Information (Cerner Multum)
• Cidofovir Intravenous Advanced Consumer Information (Micromedex)
• Cidofovir AHFS DI Monographs (ASHP)